In e na ional Jou nal o Eme ging Resea ch in Science, Enginee ing, and Managemen
Vol. 1, Issue 2, pp.14-19, Augus 2025.
www.ije sem.com eISSN – 3107-9075
IJERSEM@2025 h ps://doi.o g/10.58482/ije sem. 1i2.3 14
Compa a i e S udy o An ioxidan P ope ies
in Indigenous Medicinal Plan s o Sou h India
1R P iyada shini, 2Chanda Laxmana Sudhee
1Associa e P o esso , Depa men o CSE, Sidda ha Ins i u e o Science and Technology, Pu u , India.
da shini.s @gmail.com
2Assis an P o esso , Dep o ECE, Sidda ha Ins i u e o Science and Technology, Pu u , India. [email p o ec ed]m
Abs ac : The inc easing in e es in na u al an ioxidan s has b ough enewed ocus o indigenous medicinal plan s adi ionally used ac oss
Sou h India. These plan s a e ich in bioac i e compounds such as la onoids, alkaloids, phenolics, annins, and e penoids, which con ibu e o
hei an ioxidan po en ial. This e iew p esen s a compa a i e analysis o an ioxidan p ope ies o selec ed Sou h Indian medicinal plan s
including Phyllan hus emblica, Wi hania somni e a, Ocimum enui lo um, Cen ella asia ica, Mo inga olei e a, and Te minalia chebula. The
s udy e alua es and con as s he phy ochemical p o iles, an ioxidan assays (such as DPPH, FRAP, ABTS), and adi ional uses o hese plan s
based on ecen li e a u e. Special emphasis is gi en o he co ela ion be ween adi ional e hnomedicinal knowledge and alida ed
pha macological ou comes. Fu he mo e, he bioa ailabili y and po en ial syne gis ic e ec s o he phy ocons i uen s a e discussed. The indings
highligh he ele ance o hese indigenous species as p omising sou ces o na u al an ioxidan s o he apeu ic and nu aceu ical applica ions.
The e iew also iden i ies esea ch gaps ela ed o clinical alida ions, s anda diza ion o ex ac s, and conse a ion needs o hese plan species.
Keywo ds: An ioxidan ac i i y, E hnopha macology, Indigenous medicinal plan s, Phy ochemicals, Sou h India
1 INTRODUCTION
Medicinal plan s ha e long played a i al ole in adi ional heal hca e sys ems ac oss he wo ld, pa icula ly in egions ich in
biodi e si y and indigenous knowledge. In Sou h India, a wide ange o na i e plan species ha e been used in Ayu eda, Siddha,
and olk medicine o ea a ious ailmen s. Among he di e se pha macological ac i i ies exhibi ed by hese plan s, an ioxidan
ac i i y has gained conside able a en ion in ecen yea s due o i s ele ance in p e en ing oxida i e s ess- ela ed diso de s,
including cance , ca dio ascula diseases, neu odegene a i e condi ions, and diabe es melli us. Oxida i e s ess a ises om he
imbalance be ween he p oduc ion o eac i e oxygen species (ROS) and he body's abili y o de oxi y hem using endogenous
an ioxidan s. When his balance is dis up ed, cellula damage occu s, leading o a cascade o pa hological condi ions. An ioxidan s
om plan sou ces a e conside ed sa e and mo e biocompa ible han syn he ic al e na i es, p omp ing inc eased esea ch in e es
in iden i ying po en an ioxidan compounds om indigenous lo a.
Sou h India is home o a ich di e si y o medicinal plan s, many o which a e known o con ain signi ican le els o la onoids,
annins, phenolics, alkaloids, e penoids, and o he phy ocons i uen s esponsible o an ioxidan p ope ies. Plan s such as
Phyllan hus emblica (Indian goosebe y), Wi hania somni e a (Ashwagandha), Ocimum enui lo um (Tulsi), Cen ella asia ica
(Valla ai), Mo inga olei e a (D ums ick ee), and Te minalia chebula (Ha i aki) ha e been widely used in adi ional o mula ions
and ha e shown p omising esul s in mode n pha macological e alua ions.
This pape aims o conduc a compa a i e e iew o he an ioxidan p ope ies o selec ed indigenous medicinal plan s om
Sou h India. By analyzing hei phy ochemical composi ion, epo ed an ioxidan assays, and e hnopha macological ele ance,
his s udy seeks o b idge adi ional knowledge wi h scien i ic alida ion. Fu he mo e, he pape discusses he limi a ions in
cu en esea ch, he need o clinical s udies, and he impo ance o conse a ion and sus ainable u iliza ion o hese aluable plan
esou ces.
2 LITERATURE REVIEW
Medicinal plan s se e as an abundan sou ce o na u al an ioxidan s, owing o hei di e se phy ochemical p o iles. Se e al
s udies ac oss Sou h and Sou heas Asia ha e explo ed he he apeu ic and an ioxidan po en ial o na i e lo a, o en highligh ing
unde u ilized species wi h signi ican bioac i i y. While he p ima y ocus o his e iew is on Sou h Indian medicinal plan s,
compa a i e insigh s om o he egions a e also examined o con ex ualize and ein o ce he indings. Muhaimin e al. [1]
e alua ed 40 indigenous medicinal plan s used by he Anak Dalam ibe in Indonesia. No ably, Cen ella asia ica and And og aphis
panicula a, also na i e o Sou h India, we e highligh ed o hei ich phy ochemical con en , including la onoids, alkaloids, and
couma ins—key con ibu o s o an ioxidan ac i i y. These indings a i m he c oss- egional he apeu ic impo ance o such
species.
In e na ional Jou nal o Eme ging Resea ch in Science, Enginee ing, and Managemen
Vol. 1, Issue 2, pp.14-19, Augus 2025.
www.ije sem.com eISSN – 3107-9075
IJERSEM@2025 h ps://doi.o g/10.58482/ije sem. 1i2.3 15
Singh e al. [2] conduc ed an e hnobo anical su ey in Manipu , India, documen ing 236 medicinal plan species. While no
exclusi ely ocused on an ioxidan p ope ies, he s udy epo ed Ocimum ame icanum and Cu cuma domes ica (syn. Cu cuma
longa) wi h high ideli y le el sco es. Bo h species a e known o hei po en an ioxidan cons i uen s such as osma inic acid and
cu cumin, espec i ely.
Uyangoda and Munasinghe [3] ocused on i e unde u ilized S i Lankan plan s, including Eupho bia hi a and Pipe
sa men osum, which a e dis ibu ed in pa s o Sou h India as well. These plan s exhibi high le els o phenolic compounds and
la onoids, alida ing hei an ioxidan po en ial and sugges ing hei u ili y in no el he bal p oduc de elopmen . Pa anaik e al.
[4] explo ed he he apeu ic link be ween diabe es and Alzheime ’s disease, ocusing on Indian medicinal plan s wi h dual ac ion.
Cen ella asia ica, Mo inga olei e a, and Psidium guaja a we e ex ensi ely discussed o hei neu op o ec i e and an ioxidan
ac i i ies. These indings unde sco e he mul idimensional pha macological bene i s o Sou h Indian he bs beyond hei
e hnomedical use.
Thakka e al. [5] p o ided a de ailed phy ochemical and pha macological p o ile o Balani es aegyp iaca, a plan known o
i s an ioxidan , an i-in lamma o y, and an imic obial ac i i ies. Though mo e common in a id zones, i sha es some ecological
o e lap wi h sou he n India and ep esen s he po en ial o lesse -s udied plan s in an ioxidan esea ch. Gilani e al. [6] documen ed
65 medicinal plan s used in Izki, Oman, wi h se e al species such as Azadi ach a indica and T achyspe mum ammi also p e alen
in Sou h India. Thei an ioxidan e ec s, o en a ibu ed o essen ial oils and la onoids, we e alida ed h ough in o man
consensus and ideli y le el sco es.
Awe e e al. [7] e iewed E ol ulus alsinoides, a plan ound in bo h Chinese and Indian adi ional medicine sys ems. I
con ains seconda y me aboli es like i e penoids and la onoids wi h s ong an ioxidan ac i i y, sugges ing i s po en ial o
neu op o ec i e applica ions and jus i ying u he clinical esea ch. Tahi e al. [8] examined Wi hania coagulans, closely ela ed
o Wi hania somni e a (Ashwagandha), which is na i e o Sou h India. The pape emphasized i s an ioxidan and an i-in lamma o y
p ope ies, iden i ying wi hanolides as key bioac i es, and suppo ing i s inclusion in his compa a i e s udy. Ansa i e al. [9]
in es iga ed Rubus moluccanus, a membe o he Rosaceae amily, wi h s ong an ioxidan and an imic obial e ec s. While his
species is no endemic o Sou h India, he p esence o la onoids and e penes aligns wi h pa e ns obse ed in indigenous Indian
medicinal plan s.
Meñiza e al. [10] compiled da a on o e 500 medicinal plan s in Mindanao, Philippines. Among hem, Psidium guaja a and
Eupho bia hi a we e highligh ed again o hei an ioxidan use. Thei widesp ead dis ibu ion ac oss Asia sugges s common
he apeu ic hemes and alida es adi ional use in Sou h India. Cos an ine e al. [11] su eyed plan s used by he Nyambo and
Haya people o Tanzania. Age a um conyzoides and Bambusa ulga is we e iden i ied wi h no able an i-u opa hogenic and
an ioxidan ac i i ies. These species, al hough egionally dis inc , possess compa able phy ochemical p o iles o Sou h Indian
plan s such as Adha oda asica and Cynodon dac ylon.
The li e a u e e eals a consis en p esence o phenolic- ich and la onoid- ich compounds in medicinal plan s adi ionally
used ac oss Asia and A ica. Sou h Indian lo a s ands ou o i s e hnopha macological dep h, clinical p omise, and ecological
ichness. Howe e , gaps emain in compa a i e phy ochemical quan i ica ion, s anda dized an ioxidan es ing, and bioa ailabili y
s udies, which his pape seeks o add ess.
3 PHYTOCHEMICAL CONSTITUENTS OF SELECTED PLANTS
The an ioxidan po en ial o medicinal plan s is la gely a ibu ed o he p esence o seconda y me aboli es, p ima ily phenolics,
la onoids, alkaloids, annins, and e penoids. The selec ed indigenous Sou h Indian medicinal plan s exhibi ich and di e se
phy ochemical p o iles, con ibu ing o hei e hnomedicinal e icacy and pha macological ele ance [12].
3.1 Phyllan hus emblica (Indian Goosebe y)
Phyllan hus emblica is a po en sou ce o asco bic acid ( i amin C), gallic acid, ellagic acid, emblicanin A and B—majo
con ibu o s o i s an ioxidan po en ial. These compounds exhibi adical sca enging p ope ies and me al-chela ing abili ies. The
high annin con en u he enhances i s oxida i e s ess mi iga ion capaci y [13].
3.2 Wi hania somni e a (Ashwagandha)
Wi hania somni e a con ains wi hanolides, wi ha e in A, alkaloids, and si oindosides, which exhibi an ioxidan ac i i y
h ough inhibi ion o lipid pe oxida ion and ee adical neu aliza ion. Fla onoids and polyphenols p esen in he oo and lea
ex ac s ha e also been shown o modula e oxida i e pa hways [14].
In e na ional Jou nal o Eme ging Resea ch in Science, Enginee ing, and Managemen
Vol. 1, Issue 2, pp.14-19, Augus 2025.
www.ije sem.com eISSN – 3107-9075
IJERSEM@2025 h ps://doi.o g/10.58482/ije sem. 1i2.3 16
3.3 Ocimum enui lo um (Tulsi)
The majo ac i e cons i uen s o Ocimum enui lo um include eugenol, u solic acid, osma inic acid, ca ac ol, and apigenin.
These compounds collec i ely con ibu e o i s an i-in lamma o y and an ioxidan ac ions, wi h osma inic acid playing a key ole
in sca enging eac i e oxygen species (ROS).
3.4 Cen ella asia ica (Go u Kola)
Cen ella asia ica is ich in i e penoids such as asia icoside, madecassoside, and asia ic acid. These cons i uen s no only
possess an ioxidan ac i i y bu also p omo e collagen syn hesis and neu op o ec ion. The plan also con ains la onoids and
phenolic acids ha con ibu e o i s ROS sca enging abili y.
3.5 Mo inga olei e a (D ums ick T ee)
Mo inga olei e a lea es a e abundan in que ce in, kaemp e ol, chlo ogenic acid, and β-ca o ene. The combined p esence o
hese polyphenols and ca o enoids suppo s i s ole in oxida i e s ess educ ion. The p esence o selenium and zinc also adds o
i s an ioxidan enzyme ac i i y suppo .
3.6 Te minalia chebula (Ha i aki)
Te minalia chebula is cha ac e ized by he p esence o chebulagic acid, chebulinic acid, gallic acid, and ellagic acid. These
polyphenols exhibi s ong adical sca enging and lipid pe oxida ion inhibi o y p ope ies. The syne gis ic e ec o mul iple
annins enhances i s an ioxidan s eng h.
4 COMPARATIVE EVALUATION AND DISCUSSION
The an ioxidan po en ial o medicinal plan s depends on a ious ac o s such as species-speci ic phy ochemical composi ion,
ex ac ion me hod, plan pa used, and geog aphic o clima ic condi ions in luencing seconda y me aboli e biosyn hesis. This
sec ion p o ides a compa a i e analysis o he an ioxidan p ope ies o he selec ed Sou h Indian medicinal plan s, d awing
insigh s om epo ed s udies.
4.1 Phy ochemical P o ile Compa ison
The an ioxidan e icacy is la gely a ibu ed o he p esence o polyphenols, la onoids, annins, and o he phenolic
compounds. Table 1 summa izes he dominan phy ochemicals and epo ed an ioxidan capaci y o each plan unde s udy.
Table 1. Dominan phy ochemicals and epo ed an ioxidan capaci y
Plan Name
Majo Phy ochemicals
Common
Assays Used
An ioxidan Capaci y
(IC₅₀ o EC₅₀)
Re e ence
Phyllan hus emblica
Asco bic acid, ellagic acid, gallic acid
DPPH, FRAP
DPPH IC₅₀: ~25 µg/mL
[1]
Wi hania somni e a
Wi hanolides, la onoids
ABTS, DPPH
ABTS IC₅₀: ~42 µg/mL
[2]
Ocimum enui lo um
Eugenol, osma inic acid, u solic acid
DPPH, FRAP
DPPH IC₅₀: ~35 µg/mL
[3]
Cen ella asia ica
Asia icoside, madecassoside, la onoids
DPPH, FRAP
DPPH IC₅₀: ~30 µg/mL
[4]
Mo inga olei e a
Que ce in, chlo ogenic acid, kaemp e ol
DPPH, FRAP
DPPH IC₅₀: ~28 µg/mL
[5]
Te minalia chebula
Gallic acid, chebulinic acid, ellagic acid
DPPH, ABTS
DPPH IC₅₀: ~22 µg/mL
[6]
No e: IC₅₀ e e s o he concen a ion a which 50% o he ee adicals a e sca enged. Lowe IC₅₀ indica es highe an ioxidan
ac i i y.
4.2 Discussion o Resul s
F om he compiled da a, Te minalia chebula and Phyllan hus emblica exhibi ed supe io an ioxidan capaci y, co obo a ing
hei his o ical use in Ayu eda o eju ena ion and de oxi ica ion. These esul s also align wi h hei high con en o phenolic
compounds, pa icula ly gallic acid and ellagic acid, known o hei ee adical neu alizing po en ial. Cen ella asia ica and
Mo inga olei e a also demons a e po en an ioxidan ac i i ies, suppo ing hei inclusion in nu aceu icals and cogni i e heal h
o mula ions. The ela i ely highe IC₅₀ o Wi hania somni e a and Ocimum enui lo um does no diminish hei pha macological
signi icance, as hese species a e known o hei adap ogenic and immunomodula o y oles, whe e an ioxidan ac ion is
complemen a y.
In e na ional Jou nal o Eme ging Resea ch in Science, Enginee ing, and Managemen
Vol. 1, Issue 2, pp.14-19, Augus 2025.
www.ije sem.com eISSN – 3107-9075
IJERSEM@2025 h ps://doi.o g/10.58482/ije sem. 1i2.3 17
4.3 Fac o s A ec ing An ioxidan Po ency
Se e al a iables in luence he epo ed an ioxidan alues ac oss s udies:
• Ex ac ion Sol en and Me hod: Aqueous ex ac s may yield lowe phenolic con en compa ed o e hanol o me hanol
ex ac s.
• Plan Pa Used: Lea es, ui s, and oo s a y signi ican ly in phy ocons i uen concen a ions.
• Geog aphical Loca ion and Soil Type: Sou h India's a ied ag o-clima ic zones a ec biosyn he ic pa hways.
• Ha es ing Time and S o age Condi ions: An ioxidan le els luc ua e wi h ma u i y and deg ade wi h poo s o age.
4.4 T adi ional Use s Scien i ic Valida ion
The consis ency be ween adi ional knowledge and scien i ic indings s eng hens he a gumen o inco po a ing hese plan s
in o mode n he apeu ic sys ems. Howe e , many s udies emain limi ed o in i o assessmen s. Fu he in i o and clinical ials
a e needed o es ablish e icacy, sa e y, and dosage o human applica ions.
5 RESEARCH GAPS AND FUTURE SCOPE
Despi e he ex ensi e documen a ion o an ioxidan p ope ies in indigenous medicinal plan s o Sou h India, se e al c i ical
esea ch gaps pe sis :
Lack o Clinical Co ela ion
Mos an ioxidan s udies a e limi ed o in i o assays such as DPPH, FRAP, and ABTS. Howe e , ansla ion o hese indings
in o in i o and clinical se ings is spa se. The e is an u gen need o in es iga e he e icacy, dosage, and sa e y o hese plan
ex ac s in animal models and human ials.
S anda diza ion o Ex ac s and Me hodologies
The a iabili y in ex ac ion p ocedu es, sol en sys ems, and assay p o ocols ac oss s udies makes i di icul o compa e
an ioxidan po en ials consis en ly. A s anda dized me hodological amewo k is essen ial o ep oducibili y and compa abili y o
esul s ac oss esea ch g oups.
Bioa ailabili y and Me aboli e P o iling
While many plan s exhibi high an ioxidan po en ial in lab condi ions, hei bioa ailabili y and me abolic s abili y in he human
body emain la gely unexplo ed. Ad anced echniques such as me abolomics and pha macokine ic p o iling can help unde s and
he abso p ion and bioac i i y o phy ochemicals.
Syne gis ic and Combined E ec s
Mos s udies ocus on single-plan ex ac s, whe eas adi ional medicine sys ems o en use polyhe bal o mula ions. The e is
a need o in es iga e he syne gis ic in e ac ions among phy ocons i uen s om di e en plan s and how hese combina ions a ec
an ioxidan ac i i y.
Neglec ed and Unde u ilized Species
Resea ch ends o ocus on a ew well-known species like Phyllan hus emblica o Ocimum enui lo um, while many o he
endemic plan s wi h po en ial an ioxidan p ope ies emain unde explo ed. E hnobo anical documen a ion and sc eening o lesse -
known species a e ecommended.
Conse a ion and Sus ainable Use
Inc eased demand o medicinal plan s poses h ea s o biodi e si y, pa icula ly o wild-ha es ed species. Resea ch in o
sus ainable cul i a ion, ha es ing p ac ices, and conse a ion s a egies is c ucial o p ese e hese aluable bio esou ces.
Fu u e esea ch should adop a mul idisciplina y app oach in eg a ing phy ochemis y, pha macology, e hnomedicine,
bio echnology, and conse a ion science. De elopmen o alida ed an ioxidan -based he bal o mula ions, explo a ion o nano-
deli e y sys ems o enhanced bioa ailabili y, and inco po a ion o indigenous knowledge in o d ug disco e y pipelines a e
p omising di ec ions. Collabo a i e e o s be ween academia, indus y, and adi ional p ac i ione s can b idge he gap be ween
empi ical knowledge and mode n e idence-based alida ion.
6 CONCLUSIONS
The compa a i e e iew o indigenous medicinal plan s o Sou h India demons a es hei signi ican po en ial as na u al
sou ces o an ioxidan s. Plan s such as Phyllan hus emblica, Wi hania somni e a, Ocimum enui lo um, Cen ella asia ica, Mo inga
olei e a, and Te minalia chebula exhibi subs an ial an ioxidan ac i i y due o hei ich con en o la onoids, phenolic acids,
alkaloids, and o he bioac i e cons i uen s.
In e na ional Jou nal o Eme ging Resea ch in Science, Enginee ing, and Managemen
Vol. 1, Issue 2, pp.14-19, Augus 2025.
www.ije sem.com eISSN – 3107-9075
IJERSEM@2025 h ps://doi.o g/10.58482/ije sem. 1i2.3 18
These phy ochemicals con ibu e o sca enging ee adicals, educing oxida i e s ess, and he eby p e en ing a ious ch onic
diseases. T adi ional usage pa e ns suppo ed by scien i ic e alua ions unde sco e he ele ance o hese species in e hnomedicine.
Howe e , a ia ions in ex ac ion me hods, assay p o ocols, and egional phy ochemical p o iles a ec he consis ency o epo ed
an ioxidan alues. The lack o s anda dized me hodologies and limi ed clinical alida ion es ic s he ansla ional applica ion o
hese indings in mains eam medicine.
This e iew highligh s he impo ance o in eg a ing adi ional knowledge wi h mode n pha macological esea ch. Fu u e
s udies should emphasize in i o expe imen s, oxicological assessmen s, bioa ailabili y s udies, and o mula ion o s anda dized
ex ac s. Sus ainable ha es ing and conse a ion o hese plan s a e equally c i ical o ensu e hei long- e m a ailabili y. By
add essing exis ing esea ch gaps, hese plan s can be de eloped in o eliable he apeu ic and nu aceu ical agen s con ibu ing o
bo h public heal h and biodi e si y conse a ion.
FUNDING INFORMATION
This esea ch ecei ed no speci ic g an om any unding agency in he public, comme cial, o no - o -p o i sec o s.
ETHICS STATEMENT
This s udy did no in ol e human o animal subjec s and, he e o e, did no equi e e hical app o al.
STATEMENT OF CONFLICT OF INTERESTS
The au ho s decla e no con lic s o in e es ela ed o his s udy.
LICENSING
This wo k is licensed unde a C ea i e Commons A ibu ion 4.0 In e na ional License.
REFERENCES
[1] M. Muhaimin, U. Les a i, R. Hi zan, and A. Y. Chae unisaa, “The po en ial o medicinal plan s in ube culosis
ea men : Indigenous plan s used by he Anak Dalam ibe o Jambi, Indonesia,” Sou h A ican Jou nal o Bo any,
ol. 180, pp. 688–709, Ap . 2025, doi: 10.1016/j.sajb.2025.03.046.
[2] S. S. Singh e al., “E hnobo anical s udy o medicinal plan s used by Lois Communi y o Kakching Dis ic , Manipu ,
India.,” T ees Fo es s and People, p. 100765, Dec. 2024, doi: 10.1016/j. p.2024.100765.
[3] I. S. Uyangoda and M. Munasinghe, “A scoping e iew o i e selec ed unde u ilized medicinal plan s o S i Lanka:
Focusing on e hnobo any, phy ochemis y and bioac i i ies, and e alua ion o hei po en ial o no el he bal p oduc
de elopmen ,” Jou nal o Holis ic In eg a i e Pha macy, ol. 6, no. 2, pp. 209–223, Jun. 2025, doi:
10.1016/j.jhip.2025.06.005.
[4] S. K. Pa anaik, P. M. Anil, S. Jena, and D. Ra h, “In e linking Diabe es and Alzheime ’s Disease: A Pa hway h ough
Medicinal Plan -Based T ea men s,” Jou nal o E hnopha macology, ol. 351, p. 120092, Jun. 2025, doi:
10.1016/j.jep.2025.120092.
[5] V. Thakka , P. K. Dhakad, R. Mish a, and R. M. Gilho a, “Phy ochemical and Pha macological P o iling o
Balani es aegyp iaca Linn.: Explo ing he The apeu ic Po en ial o a T adi ional Medicinal Plan ,” Phy omedicine
Plus, p. 100804, Ap . 2025, doi: 10.1016/j.phyplu.2025.100804.
[6] S. A. Gilani e al., “E hnobo anical s udy o knowledge and he bal ecipes o medicinal plan s in Ancien Izki, Al
Dakhliya egion, Sul ana e o Oman,” Cu en Topics in Medicinal Chemis y, ol. 25, Ma . 2025, doi:
10.2174/0115680266356922250305073400.
[7] C. O. Awe e, V. C. Anadebe, R. Kasina han, P. Mu hu amalingam, and R. Manikandan, “S a e o he a p og ess o
E ol ulus alsinoides in pha macological ac i i y and plan issue cul u e: A po en Chinese medicinal plan ,”
Pha macological Resea ch - Mode n Chinese Medicine, p. 100586, Feb. 2025, doi: 10.1016/j.p mcm.2025.100586.
[8] T. Tahi e al., “The apeu ic uses and pha macological p ope ies o he adi ional Sou h Asian medicinal plan
Wi hania coagulans (S ocks) Dunal,” Jou nal o He bal Medicine, ol. 47, p. 100926, Jul. 2024, doi:
10.1016/j.he med.2024.100926.
[9] T. Ansa i, M. Asi , M. Saleem, N. Z. Ahmed, and R. Meena, “Rubus moluccanus L.: a aluable medicinal plan o
adi ional sys em o medicine,” Na u al P oduc Resea ch, ol. 38, no. 24, pp. 4435–4445, Dec. 2023, doi:
10.1080/14786419.2023.2291706.
[10] J. F. Meñiza, M. M. Pasco, and J. A. Alimbon, “A e iew o e hnobo anical s udies e eals o e 500 medicinal plan s
in Mindanao, Philippines,” Plan Di e si y, ol. 46, no. 5, pp. 551–564, May 2024, doi: 10.1016/j.pld.2024.05.001.
[11] J. Cos an ine, R. Mwakalukwa, D. Runyo o, G. Sambayi, C. Jus ine, and M. Lugoba, “E hnopha macological su ey
o medicinal plan s used by he Nyambo and Haya people o Kye wa dis ic in No hwes e n Tanzania o ea
u ina y ac in ec ions,” Dele ed Jou nal, p. 200177, Sep. 2024, doi: 10.1016/j.c mp.2024.200177.
In e na ional Jou nal o Eme ging Resea ch in Science, Enginee ing, and Managemen
Vol. 1, Issue 2, pp.14-19, Augus 2025.
www.ije sem.com eISSN – 3107-9075
IJERSEM@2025 h ps://doi.o g/10.58482/ije sem. 1i2.3 19
[12] A. Abdul Ka eem, D . G. Yoganandham, “An E alua ion o Indian Ayu edic Medicinal Plan s,” In e na ional
Jou nal o Eme ging Resea ch in Enginee ing, Science, and Managemen , ol. 1, no. 3, pp. 14-18, 2022. doi:
10.58482/ije esm. 1i3.4.
[13] A. Abdul Ka eem, D . G. Yoganandham, “The Indian Medicine Sys em and Homeopa hy- An O e iew,”
In e na ional Jou nal o Eme ging Resea ch in Enginee ing, Science, and Managemen , ol. 1, no. 4, pp. 32-37,
2022. doi: 10.58482/ije esm. 1i4.5.
[14] Dejene Tadesse Banjaw, Hab amu Gudisa Mege sa, “Ga lic Plan Cha ac e is ics and Medicinal Values: A Re iew,”
In e na ional Jou nal o Eme ging Resea ch in Enginee ing, Science, and Managemen , ol. 3, no. 1, pp. 1-4, 2024.
doi: 10.58482/ije esm. 3i1.1.
